No Data
Citi Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $107
Boston Scientific Price Target Raised to $107 From $98 at Citi
Why Boston Scientific Corporation (NYSE:BSX) Could Be Worth Watching
Wells Fargo Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $98
Boston Scientific's Promising Clinical Trials and Innovative Approaches Justify Buy Rating
Market Falls Wednesday, but Googles Chip Impresses | WST